Hylenex Halozyme Therapeutics/Baxter Healthcare Corporation - Treatment for Adjuvant Agent to Enhance Drug Delivery
Hylenex recombinant is a purified preparation of the enzyme
recombinant human hyaluronidase, indicated for use as an adjuvant
agent to increase the absorption and dispersion of other injected
drugs, for hypodermoclysis, and as an adjunct in subcutaneous
urography for improving resorption of radiopaque agents.
Posted: December 2005
Hylenex (hyaluronidase) FDA Approval History